
Sands Capital Ventures
Description
Sands Capital Ventures is the private investment arm of Sands Capital Management, a global investment firm based in Arlington, Virginia. Founded in 1992, Sands Capital Management has grown to manage approximately $40 billion in assets as of December 31, 2023, reflecting its long-standing presence and expertise in public and private markets. Sands Capital Ventures extends this legacy into the private sector, focusing on high-growth, innovative businesses across various stages.
The venture arm primarily targets companies in the technology, healthcare, and business services sectors, seeking out disruptive technologies and strong management teams. Their investment strategy is characterized by a long-term, fundamental research-driven approach, aiming to partner with companies from their Series A funding rounds through to pre-IPO and public listing. This broad stage focus allows them to support companies throughout their growth trajectory, providing capital and strategic guidance as they scale.
Sands Capital Ventures is known for its significant capital deployment, often participating in substantial growth equity rounds. While their specific check sizes can vary widely depending on the stage and needs of the company, typical initial investments for high-growth opportunities can range from approximately $10 million for earlier-stage Series A rounds to upwards of $75 million for more mature growth equity deals. They are not merely capital providers but seek to leverage their deep industry knowledge and extensive network to help portfolio companies achieve their long-term strategic objectives and market leadership.
Their commitment to identifying and nurturing companies with sustainable competitive advantages underscores their investment philosophy. Sands Capital Ventures looks for businesses poised for significant market expansion and enduring value creation, aligning with their parent firm's overarching focus on quality growth investments.
Investor Profile
Sands Capital Ventures has backed more than 186 startups, with 21 new investments in the last 12 months alone. The firm has led 51 rounds, about 27% of its total and boasts 39 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, India.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Led 7 rounds in the past year.
- Typical check size: $10M – $75M.
Stage Focus
- Series B (19%)
- Series A (17%)
- Series C (15%)
- Series D (10%)
- Series E (10%)
- Series Unknown (9%)
- Series F (6%)
- Seed (6%)
- Series G (3%)
- Private Equity (2%)
Country Focus
- United States (78%)
- United Kingdom (6%)
- India (5%)
- Canada (5%)
- Germany (2%)
- Ireland (2%)
- Israel (1%)
- Brazil (1%)
- Australia (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Artificial Intelligence (Ai)
- Health Diagnostics
- Information Technology
- Medical
- Medical Device
- Enterprise Software
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.